Stocks
Merck & Co., Inc.MRK
NYSEHealthcarePharmaceuticals$115.62-0.25%
A global pharmaceutical manufacturer focused on prescription medicines, vaccines, and biologic therapies, with major franchises in oncology, infectious diseases, and animal health. Its cancer immunotherapy Keytruda is one of the world’s highest‑selling drugs and a primary driver of revenue growth. I...
Market Cap: $285.9B52W Range: $73.31 – $125.14
Congressional Interest in Merck & Co., Inc. (MRK)
15 members of Congress have disclosed 50 trades in Merck & Co., Inc. (MRK), a Healthcare company. The buy/sell breakdown shows 24 purchases versus 26 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
15
Buys
24
Sells
26
Who in Congress Is Trading MRK?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-02-24 | Jefferson Shreve | buy | $15K – $50K |
| 2025-02-19 | Rohit Khanna | buy | $50K – $100K |